Medical Devices & Consumables
Global Liposomes for Drug Delivery Market Research Report 2025
- Mar 11, 25
- ID: 77691
- Pages: 103
- Figures: 101
- Views: 13
The global market for Liposomes for Drug Delivery was valued at US$ 3550 million in the year 2024 and is projected to reach a revised size of US$ 4383 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposomes for Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes for Drug Delivery.
The Liposomes for Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomes for Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomes for Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Segment by Type
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liposomes for Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liposomes for Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposomes for Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes for Drug Delivery.
The Liposomes for Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomes for Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomes for Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Segment by Type
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liposomes for Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liposomes for Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Liposomes for Drug Delivery Market Overview
1.1 Product Definition
1.2 Liposomes for Drug Delivery by Type
1.2.1 Global Liposomes for Drug Delivery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liposome Vitamin
1.2.3 Liposome Ceramide
1.2.4 Liposome CoQ10
1.2.5 Others
1.3 Liposomes for Drug Delivery by Application
1.3.1 Global Liposomes for Drug Delivery Market Value by Application (2024 VS 2031)
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Global Liposomes for Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Liposomes for Drug Delivery Revenue 2020-2031
1.4.2 Global Liposomes for Drug Delivery Sales 2020-2031
1.4.3 Global Liposomes for Drug Delivery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Liposomes for Drug Delivery Market Competition by Manufacturers
2.1 Global Liposomes for Drug Delivery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Liposomes for Drug Delivery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Liposomes for Drug Delivery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Liposomes for Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liposomes for Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liposomes for Drug Delivery, Product Type & Application
2.7 Global Key Manufacturers of Liposomes for Drug Delivery, Date of Enter into This Industry
2.8 Global Liposomes for Drug Delivery Market Competitive Situation and Trends
2.8.1 Global Liposomes for Drug Delivery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Liposomes for Drug Delivery Players Market Share by Revenue
2.8.3 Global Liposomes for Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Liposomes for Drug Delivery Market Scenario by Region
3.1 Global Liposomes for Drug Delivery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Liposomes for Drug Delivery Sales by Region: 2020-2031
3.2.1 Global Liposomes for Drug Delivery Sales by Region: 2020-2025
3.2.2 Global Liposomes for Drug Delivery Sales by Region: 2026-2031
3.3 Global Liposomes for Drug Delivery Revenue by Region: 2020-2031
3.3.1 Global Liposomes for Drug Delivery Revenue by Region: 2020-2025
3.3.2 Global Liposomes for Drug Delivery Revenue by Region: 2026-2031
3.4 North America Liposomes for Drug Delivery Market Facts & Figures by Country
3.4.1 North America Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Liposomes for Drug Delivery Sales by Country (2020-2031)
3.4.3 North America Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Liposomes for Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Liposomes for Drug Delivery Sales by Country (2020-2031)
3.5.3 Europe Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposomes for Drug Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Liposomes for Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Liposomes for Drug Delivery Sales by Region (2020-2031)
3.6.3 Asia Pacific Liposomes for Drug Delivery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liposomes for Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Liposomes for Drug Delivery Sales by Country (2020-2031)
3.7.3 Latin America Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposomes for Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Liposomes for Drug Delivery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liposomes for Drug Delivery Sales by Type (2020-2031)
4.1.1 Global Liposomes for Drug Delivery Sales by Type (2020-2025)
4.1.2 Global Liposomes for Drug Delivery Sales by Type (2026-2031)
4.1.3 Global Liposomes for Drug Delivery Sales Market Share by Type (2020-2031)
4.2 Global Liposomes for Drug Delivery Revenue by Type (2020-2031)
4.2.1 Global Liposomes for Drug Delivery Revenue by Type (2020-2025)
4.2.2 Global Liposomes for Drug Delivery Revenue by Type (2026-2031)
4.2.3 Global Liposomes for Drug Delivery Revenue Market Share by Type (2020-2031)
4.3 Global Liposomes for Drug Delivery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Liposomes for Drug Delivery Sales by Application (2020-2031)
5.1.1 Global Liposomes for Drug Delivery Sales by Application (2020-2025)
5.1.2 Global Liposomes for Drug Delivery Sales by Application (2026-2031)
5.1.3 Global Liposomes for Drug Delivery Sales Market Share by Application (2020-2031)
5.2 Global Liposomes for Drug Delivery Revenue by Application (2020-2031)
5.2.1 Global Liposomes for Drug Delivery Revenue by Application (2020-2025)
5.2.2 Global Liposomes for Drug Delivery Revenue by Application (2026-2031)
5.2.3 Global Liposomes for Drug Delivery Revenue Market Share by Application (2020-2031)
5.3 Global Liposomes for Drug Delivery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lipoid Kosmetik
6.1.1 Lipoid Kosmetik Company Information
6.1.2 Lipoid Kosmetik Description and Business Overview
6.1.3 Lipoid Kosmetik Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lipoid Kosmetik Liposomes for Drug Delivery Product Portfolio
6.1.5 Lipoid Kosmetik Recent Developments/Updates
6.2 Lucas Meyer Cosmetics
6.2.1 Lucas Meyer Cosmetics Company Information
6.2.2 Lucas Meyer Cosmetics Description and Business Overview
6.2.3 Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lucas Meyer Cosmetics Liposomes for Drug Delivery Product Portfolio
6.2.5 Lucas Meyer Cosmetics Recent Developments/Updates
6.3 Nippon Fine Chemical
6.3.1 Nippon Fine Chemical Company Information
6.3.2 Nippon Fine Chemical Description and Business Overview
6.3.3 Nippon Fine Chemical Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nippon Fine Chemical Liposomes for Drug Delivery Product Portfolio
6.3.5 Nippon Fine Chemical Recent Developments/Updates
6.4 Enoc Solutions
6.4.1 Enoc Solutions Company Information
6.4.2 Enoc Solutions Description and Business Overview
6.4.3 Enoc Solutions Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Enoc Solutions Liposomes for Drug Delivery Product Portfolio
6.4.5 Enoc Solutions Recent Developments/Updates
6.5 Nanovec
6.5.1 Nanovec Company Information
6.5.2 Nanovec Description and Business Overview
6.5.3 Nanovec Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nanovec Liposomes for Drug Delivery Product Portfolio
6.5.5 Nanovec Recent Developments/Updates
6.6 Lipotec
6.6.1 Lipotec Company Information
6.6.2 Lipotec Description and Business Overview
6.6.3 Lipotec Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lipotec Liposomes for Drug Delivery Product Portfolio
6.6.5 Lipotec Recent Developments/Updates
6.7 Croda
6.7.1 Croda Company Information
6.7.2 Croda Description and Business Overview
6.7.3 Croda Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Croda Liposomes for Drug Delivery Product Portfolio
6.7.5 Croda Recent Developments/Updates
6.8 H&A Pharmachem
6.8.1 H&A Pharmachem Company Information
6.8.2 H&A Pharmachem Description and Business Overview
6.8.3 H&A Pharmachem Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 H&A Pharmachem Liposomes for Drug Delivery Product Portfolio
6.8.5 H&A Pharmachem Recent Developments/Updates
6.9 Lipomize
6.9.1 Lipomize Company Information
6.9.2 Lipomize Description and Business Overview
6.9.3 Lipomize Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lipomize Liposomes for Drug Delivery Product Portfolio
6.9.5 Lipomize Recent Developments/Updates
6.10 ID bio
6.10.1 ID bio Company Information
6.10.2 ID bio Description and Business Overview
6.10.3 ID bio Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ID bio Liposomes for Drug Delivery Product Portfolio
6.10.5 ID bio Recent Developments/Updates
6.11 BioSpectrum
6.11.1 BioSpectrum Company Information
6.11.2 BioSpectrum Description and Business Overview
6.11.3 BioSpectrum Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BioSpectrum Liposomes for Drug Delivery Product Portfolio
6.11.5 BioSpectrum Recent Developments/Updates
6.12 Derma Clinical
6.12.1 Derma Clinical Company Information
6.12.2 Derma Clinical Description and Business Overview
6.12.3 Derma Clinical Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Derma Clinical Liposomes for Drug Delivery Product Portfolio
6.12.5 Derma Clinical Recent Developments/Updates
6.13 Kewpie Corporation
6.13.1 Kewpie Corporation Company Information
6.13.2 Kewpie Corporation Description and Business Overview
6.13.3 Kewpie Corporation Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kewpie Corporation Liposomes for Drug Delivery Product Portfolio
6.13.5 Kewpie Corporation Recent Developments/Updates
6.14 Nanohealth Biotech
6.14.1 Nanohealth Biotech Company Information
6.14.2 Nanohealth Biotech Description and Business Overview
6.14.3 Nanohealth Biotech Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nanohealth Biotech Liposomes for Drug Delivery Product Portfolio
6.14.5 Nanohealth Biotech Recent Developments/Updates
6.15 Creative Biostructure
6.15.1 Creative Biostructure Company Information
6.15.2 Creative Biostructure Description and Business Overview
6.15.3 Creative Biostructure Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Creative Biostructure Liposomes for Drug Delivery Product Portfolio
6.15.5 Creative Biostructure Recent Developments/Updates
6.16 Phenbiox
6.16.1 Phenbiox Company Information
6.16.2 Phenbiox Description and Business Overview
6.16.3 Phenbiox Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Phenbiox Liposomes for Drug Delivery Product Portfolio
6.16.5 Phenbiox Recent Developments/Updates
6.17 NOF CORPORATION
6.17.1 NOF CORPORATION Company Information
6.17.2 NOF CORPORATION Description and Business Overview
6.17.3 NOF CORPORATION Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.17.4 NOF CORPORATION Liposomes for Drug Delivery Product Portfolio
6.17.5 NOF CORPORATION Recent Developments/Updates
6.18 KYOWA PHARMA CHEMICAL
6.18.1 KYOWA PHARMA CHEMICAL Company Information
6.18.2 KYOWA PHARMA CHEMICAL Description and Business Overview
6.18.3 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.18.4 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product Portfolio
6.18.5 KYOWA PHARMA CHEMICAL Recent Developments/Updates
6.19 Nikko Chemicals
6.19.1 Nikko Chemicals Company Information
6.19.2 Nikko Chemicals Description and Business Overview
6.19.3 Nikko Chemicals Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Nikko Chemicals Liposomes for Drug Delivery Product Portfolio
6.19.5 Nikko Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposomes for Drug Delivery Industry Chain Analysis
7.2 Liposomes for Drug Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposomes for Drug Delivery Production Mode & Process Analysis
7.4 Liposomes for Drug Delivery Sales and Marketing
7.4.1 Liposomes for Drug Delivery Sales Channels
7.4.2 Liposomes for Drug Delivery Distributors
7.5 Liposomes for Drug Delivery Customer Analysis
8 Liposomes for Drug Delivery Market Dynamics
8.1 Liposomes for Drug Delivery Industry Trends
8.2 Liposomes for Drug Delivery Market Drivers
8.3 Liposomes for Drug Delivery Market Challenges
8.4 Liposomes for Drug Delivery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Liposomes for Drug Delivery by Type
1.2.1 Global Liposomes for Drug Delivery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liposome Vitamin
1.2.3 Liposome Ceramide
1.2.4 Liposome CoQ10
1.2.5 Others
1.3 Liposomes for Drug Delivery by Application
1.3.1 Global Liposomes for Drug Delivery Market Value by Application (2024 VS 2031)
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Global Liposomes for Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Liposomes for Drug Delivery Revenue 2020-2031
1.4.2 Global Liposomes for Drug Delivery Sales 2020-2031
1.4.3 Global Liposomes for Drug Delivery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Liposomes for Drug Delivery Market Competition by Manufacturers
2.1 Global Liposomes for Drug Delivery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Liposomes for Drug Delivery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Liposomes for Drug Delivery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Liposomes for Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liposomes for Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liposomes for Drug Delivery, Product Type & Application
2.7 Global Key Manufacturers of Liposomes for Drug Delivery, Date of Enter into This Industry
2.8 Global Liposomes for Drug Delivery Market Competitive Situation and Trends
2.8.1 Global Liposomes for Drug Delivery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Liposomes for Drug Delivery Players Market Share by Revenue
2.8.3 Global Liposomes for Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Liposomes for Drug Delivery Market Scenario by Region
3.1 Global Liposomes for Drug Delivery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Liposomes for Drug Delivery Sales by Region: 2020-2031
3.2.1 Global Liposomes for Drug Delivery Sales by Region: 2020-2025
3.2.2 Global Liposomes for Drug Delivery Sales by Region: 2026-2031
3.3 Global Liposomes for Drug Delivery Revenue by Region: 2020-2031
3.3.1 Global Liposomes for Drug Delivery Revenue by Region: 2020-2025
3.3.2 Global Liposomes for Drug Delivery Revenue by Region: 2026-2031
3.4 North America Liposomes for Drug Delivery Market Facts & Figures by Country
3.4.1 North America Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Liposomes for Drug Delivery Sales by Country (2020-2031)
3.4.3 North America Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Liposomes for Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Liposomes for Drug Delivery Sales by Country (2020-2031)
3.5.3 Europe Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposomes for Drug Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Liposomes for Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Liposomes for Drug Delivery Sales by Region (2020-2031)
3.6.3 Asia Pacific Liposomes for Drug Delivery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liposomes for Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Liposomes for Drug Delivery Sales by Country (2020-2031)
3.7.3 Latin America Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposomes for Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposomes for Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Liposomes for Drug Delivery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Liposomes for Drug Delivery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liposomes for Drug Delivery Sales by Type (2020-2031)
4.1.1 Global Liposomes for Drug Delivery Sales by Type (2020-2025)
4.1.2 Global Liposomes for Drug Delivery Sales by Type (2026-2031)
4.1.3 Global Liposomes for Drug Delivery Sales Market Share by Type (2020-2031)
4.2 Global Liposomes for Drug Delivery Revenue by Type (2020-2031)
4.2.1 Global Liposomes for Drug Delivery Revenue by Type (2020-2025)
4.2.2 Global Liposomes for Drug Delivery Revenue by Type (2026-2031)
4.2.3 Global Liposomes for Drug Delivery Revenue Market Share by Type (2020-2031)
4.3 Global Liposomes for Drug Delivery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Liposomes for Drug Delivery Sales by Application (2020-2031)
5.1.1 Global Liposomes for Drug Delivery Sales by Application (2020-2025)
5.1.2 Global Liposomes for Drug Delivery Sales by Application (2026-2031)
5.1.3 Global Liposomes for Drug Delivery Sales Market Share by Application (2020-2031)
5.2 Global Liposomes for Drug Delivery Revenue by Application (2020-2031)
5.2.1 Global Liposomes for Drug Delivery Revenue by Application (2020-2025)
5.2.2 Global Liposomes for Drug Delivery Revenue by Application (2026-2031)
5.2.3 Global Liposomes for Drug Delivery Revenue Market Share by Application (2020-2031)
5.3 Global Liposomes for Drug Delivery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lipoid Kosmetik
6.1.1 Lipoid Kosmetik Company Information
6.1.2 Lipoid Kosmetik Description and Business Overview
6.1.3 Lipoid Kosmetik Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lipoid Kosmetik Liposomes for Drug Delivery Product Portfolio
6.1.5 Lipoid Kosmetik Recent Developments/Updates
6.2 Lucas Meyer Cosmetics
6.2.1 Lucas Meyer Cosmetics Company Information
6.2.2 Lucas Meyer Cosmetics Description and Business Overview
6.2.3 Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lucas Meyer Cosmetics Liposomes for Drug Delivery Product Portfolio
6.2.5 Lucas Meyer Cosmetics Recent Developments/Updates
6.3 Nippon Fine Chemical
6.3.1 Nippon Fine Chemical Company Information
6.3.2 Nippon Fine Chemical Description and Business Overview
6.3.3 Nippon Fine Chemical Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nippon Fine Chemical Liposomes for Drug Delivery Product Portfolio
6.3.5 Nippon Fine Chemical Recent Developments/Updates
6.4 Enoc Solutions
6.4.1 Enoc Solutions Company Information
6.4.2 Enoc Solutions Description and Business Overview
6.4.3 Enoc Solutions Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Enoc Solutions Liposomes for Drug Delivery Product Portfolio
6.4.5 Enoc Solutions Recent Developments/Updates
6.5 Nanovec
6.5.1 Nanovec Company Information
6.5.2 Nanovec Description and Business Overview
6.5.3 Nanovec Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nanovec Liposomes for Drug Delivery Product Portfolio
6.5.5 Nanovec Recent Developments/Updates
6.6 Lipotec
6.6.1 Lipotec Company Information
6.6.2 Lipotec Description and Business Overview
6.6.3 Lipotec Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lipotec Liposomes for Drug Delivery Product Portfolio
6.6.5 Lipotec Recent Developments/Updates
6.7 Croda
6.7.1 Croda Company Information
6.7.2 Croda Description and Business Overview
6.7.3 Croda Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Croda Liposomes for Drug Delivery Product Portfolio
6.7.5 Croda Recent Developments/Updates
6.8 H&A Pharmachem
6.8.1 H&A Pharmachem Company Information
6.8.2 H&A Pharmachem Description and Business Overview
6.8.3 H&A Pharmachem Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 H&A Pharmachem Liposomes for Drug Delivery Product Portfolio
6.8.5 H&A Pharmachem Recent Developments/Updates
6.9 Lipomize
6.9.1 Lipomize Company Information
6.9.2 Lipomize Description and Business Overview
6.9.3 Lipomize Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lipomize Liposomes for Drug Delivery Product Portfolio
6.9.5 Lipomize Recent Developments/Updates
6.10 ID bio
6.10.1 ID bio Company Information
6.10.2 ID bio Description and Business Overview
6.10.3 ID bio Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ID bio Liposomes for Drug Delivery Product Portfolio
6.10.5 ID bio Recent Developments/Updates
6.11 BioSpectrum
6.11.1 BioSpectrum Company Information
6.11.2 BioSpectrum Description and Business Overview
6.11.3 BioSpectrum Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BioSpectrum Liposomes for Drug Delivery Product Portfolio
6.11.5 BioSpectrum Recent Developments/Updates
6.12 Derma Clinical
6.12.1 Derma Clinical Company Information
6.12.2 Derma Clinical Description and Business Overview
6.12.3 Derma Clinical Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Derma Clinical Liposomes for Drug Delivery Product Portfolio
6.12.5 Derma Clinical Recent Developments/Updates
6.13 Kewpie Corporation
6.13.1 Kewpie Corporation Company Information
6.13.2 Kewpie Corporation Description and Business Overview
6.13.3 Kewpie Corporation Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kewpie Corporation Liposomes for Drug Delivery Product Portfolio
6.13.5 Kewpie Corporation Recent Developments/Updates
6.14 Nanohealth Biotech
6.14.1 Nanohealth Biotech Company Information
6.14.2 Nanohealth Biotech Description and Business Overview
6.14.3 Nanohealth Biotech Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nanohealth Biotech Liposomes for Drug Delivery Product Portfolio
6.14.5 Nanohealth Biotech Recent Developments/Updates
6.15 Creative Biostructure
6.15.1 Creative Biostructure Company Information
6.15.2 Creative Biostructure Description and Business Overview
6.15.3 Creative Biostructure Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Creative Biostructure Liposomes for Drug Delivery Product Portfolio
6.15.5 Creative Biostructure Recent Developments/Updates
6.16 Phenbiox
6.16.1 Phenbiox Company Information
6.16.2 Phenbiox Description and Business Overview
6.16.3 Phenbiox Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Phenbiox Liposomes for Drug Delivery Product Portfolio
6.16.5 Phenbiox Recent Developments/Updates
6.17 NOF CORPORATION
6.17.1 NOF CORPORATION Company Information
6.17.2 NOF CORPORATION Description and Business Overview
6.17.3 NOF CORPORATION Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.17.4 NOF CORPORATION Liposomes for Drug Delivery Product Portfolio
6.17.5 NOF CORPORATION Recent Developments/Updates
6.18 KYOWA PHARMA CHEMICAL
6.18.1 KYOWA PHARMA CHEMICAL Company Information
6.18.2 KYOWA PHARMA CHEMICAL Description and Business Overview
6.18.3 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.18.4 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product Portfolio
6.18.5 KYOWA PHARMA CHEMICAL Recent Developments/Updates
6.19 Nikko Chemicals
6.19.1 Nikko Chemicals Company Information
6.19.2 Nikko Chemicals Description and Business Overview
6.19.3 Nikko Chemicals Liposomes for Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Nikko Chemicals Liposomes for Drug Delivery Product Portfolio
6.19.5 Nikko Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposomes for Drug Delivery Industry Chain Analysis
7.2 Liposomes for Drug Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposomes for Drug Delivery Production Mode & Process Analysis
7.4 Liposomes for Drug Delivery Sales and Marketing
7.4.1 Liposomes for Drug Delivery Sales Channels
7.4.2 Liposomes for Drug Delivery Distributors
7.5 Liposomes for Drug Delivery Customer Analysis
8 Liposomes for Drug Delivery Market Dynamics
8.1 Liposomes for Drug Delivery Industry Trends
8.2 Liposomes for Drug Delivery Market Drivers
8.3 Liposomes for Drug Delivery Market Challenges
8.4 Liposomes for Drug Delivery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Liposomes for Drug Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Liposomes for Drug Delivery Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Liposomes for Drug Delivery Market Competitive Situation by Manufacturers in 2024
Table 4. Global Liposomes for Drug Delivery Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Liposomes for Drug Delivery Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Liposomes for Drug Delivery Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Liposomes for Drug Delivery Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Liposomes for Drug Delivery Average Price (US$/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Liposomes for Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Liposomes for Drug Delivery, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liposomes for Drug Delivery, Product Type & Application
Table 12. Global Key Manufacturers of Liposomes for Drug Delivery, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomes for Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes for Drug Delivery as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liposomes for Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Liposomes for Drug Delivery Sales by Region (2020-2025) & (Tons)
Table 18. Global Liposomes for Drug Delivery Sales Market Share by Region (2020-2025)
Table 19. Global Liposomes for Drug Delivery Sales by Region (2026-2031) & (Tons)
Table 20. Global Liposomes for Drug Delivery Sales Market Share by Region (2026-2031)
Table 21. Global Liposomes for Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Liposomes for Drug Delivery Revenue Market Share by Region (2020-2025)
Table 23. Global Liposomes for Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Liposomes for Drug Delivery Revenue Market Share by Region (2026-2031)
Table 25. North America Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 27. North America Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 28. North America Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 32. Europe Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 33. Europe Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Liposomes for Drug Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Liposomes for Drug Delivery Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Liposomes for Drug Delivery Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Liposomes for Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Liposomes for Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Liposomes for Drug Delivery Sales (Tons) by Type (2020-2025)
Table 51. Global Liposomes for Drug Delivery Sales (Tons) by Type (2026-2031)
Table 52. Global Liposomes for Drug Delivery Sales Market Share by Type (2020-2025)
Table 53. Global Liposomes for Drug Delivery Sales Market Share by Type (2026-2031)
Table 54. Global Liposomes for Drug Delivery Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Liposomes for Drug Delivery Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Liposomes for Drug Delivery Revenue Market Share by Type (2020-2025)
Table 57. Global Liposomes for Drug Delivery Revenue Market Share by Type (2026-2031)
Table 58. Global Liposomes for Drug Delivery Price (US$/Kg) by Type (2020-2025)
Table 59. Global Liposomes for Drug Delivery Price (US$/Kg) by Type (2026-2031)
Table 60. Global Liposomes for Drug Delivery Sales (Tons) by Application (2020-2025)
Table 61. Global Liposomes for Drug Delivery Sales (Tons) by Application (2026-2031)
Table 62. Global Liposomes for Drug Delivery Sales Market Share by Application (2020-2025)
Table 63. Global Liposomes for Drug Delivery Sales Market Share by Application (2026-2031)
Table 64. Global Liposomes for Drug Delivery Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Liposomes for Drug Delivery Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Liposomes for Drug Delivery Revenue Market Share by Application (2020-2025)
Table 67. Global Liposomes for Drug Delivery Revenue Market Share by Application (2026-2031)
Table 68. Global Liposomes for Drug Delivery Price (US$/Kg) by Application (2020-2025)
Table 69. Global Liposomes for Drug Delivery Price (US$/Kg) by Application (2026-2031)
Table 70. Lipoid Kosmetik Company Information
Table 71. Lipoid Kosmetik Description and Business Overview
Table 72. Lipoid Kosmetik Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 73. Lipoid Kosmetik Liposomes for Drug Delivery Product
Table 74. Lipoid Kosmetik Recent Developments/Updates
Table 75. Lucas Meyer Cosmetics Company Information
Table 76. Lucas Meyer Cosmetics Description and Business Overview
Table 77. Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. Lucas Meyer Cosmetics Liposomes for Drug Delivery Product
Table 79. Lucas Meyer Cosmetics Recent Developments/Updates
Table 80. Nippon Fine Chemical Company Information
Table 81. Nippon Fine Chemical Description and Business Overview
Table 82. Nippon Fine Chemical Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. Nippon Fine Chemical Liposomes for Drug Delivery Product
Table 84. Nippon Fine Chemical Recent Developments/Updates
Table 85. Enoc Solutions Company Information
Table 86. Enoc Solutions Description and Business Overview
Table 87. Enoc Solutions Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. Enoc Solutions Liposomes for Drug Delivery Product
Table 89. Enoc Solutions Recent Developments/Updates
Table 90. Nanovec Company Information
Table 91. Nanovec Description and Business Overview
Table 92. Nanovec Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Nanovec Liposomes for Drug Delivery Product
Table 94. Nanovec Recent Developments/Updates
Table 95. Lipotec Company Information
Table 96. Lipotec Description and Business Overview
Table 97. Lipotec Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. Lipotec Liposomes for Drug Delivery Product
Table 99. Lipotec Recent Developments/Updates
Table 100. Croda Company Information
Table 101. Croda Description and Business Overview
Table 102. Croda Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. Croda Liposomes for Drug Delivery Product
Table 104. Croda Recent Developments/Updates
Table 105. H&A Pharmachem Company Information
Table 106. H&A Pharmachem Description and Business Overview
Table 107. H&A Pharmachem Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 108. H&A Pharmachem Liposomes for Drug Delivery Product
Table 109. H&A Pharmachem Recent Developments/Updates
Table 110. Lipomize Company Information
Table 111. Lipomize Description and Business Overview
Table 112. Lipomize Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 113. Lipomize Liposomes for Drug Delivery Product
Table 114. Lipomize Recent Developments/Updates
Table 115. ID bio Company Information
Table 116. ID bio Description and Business Overview
Table 117. ID bio Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 118. ID bio Liposomes for Drug Delivery Product
Table 119. ID bio Recent Developments/Updates
Table 120. BioSpectrum Company Information
Table 121. BioSpectrum Description and Business Overview
Table 122. BioSpectrum Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 123. BioSpectrum Liposomes for Drug Delivery Product
Table 124. BioSpectrum Recent Developments/Updates
Table 125. Derma Clinical Company Information
Table 126. Derma Clinical Description and Business Overview
Table 127. Derma Clinical Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 128. Derma Clinical Liposomes for Drug Delivery Product
Table 129. Derma Clinical Recent Developments/Updates
Table 130. Kewpie Corporation Company Information
Table 131. Kewpie Corporation Description and Business Overview
Table 132. Kewpie Corporation Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 133. Kewpie Corporation Liposomes for Drug Delivery Product
Table 134. Kewpie Corporation Recent Developments/Updates
Table 135. Nanohealth Biotech Company Information
Table 136. Nanohealth Biotech Description and Business Overview
Table 137. Nanohealth Biotech Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 138. Nanohealth Biotech Liposomes for Drug Delivery Product
Table 139. Nanohealth Biotech Recent Developments/Updates
Table 140. Creative Biostructure Company Information
Table 141. Creative Biostructure Description and Business Overview
Table 142. Creative Biostructure Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 143. Creative Biostructure Liposomes for Drug Delivery Product
Table 144. Creative Biostructure Recent Developments/Updates
Table 145. Phenbiox Company Information
Table 146. Phenbiox Description and Business Overview
Table 147. Phenbiox Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 148. Phenbiox Liposomes for Drug Delivery Product
Table 149. Phenbiox Recent Developments/Updates
Table 150. NOF CORPORATION Company Information
Table 151. NOF CORPORATION Description and Business Overview
Table 152. NOF CORPORATION Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 153. NOF CORPORATION Liposomes for Drug Delivery Product
Table 154. NOF CORPORATION Recent Developments/Updates
Table 155. KYOWA PHARMA CHEMICAL Company Information
Table 156. KYOWA PHARMA CHEMICAL Description and Business Overview
Table 157. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 158. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product
Table 159. KYOWA PHARMA CHEMICAL Recent Developments/Updates
Table 160. Nikko Chemicals Company Information
Table 161. Nikko Chemicals Description and Business Overview
Table 162. Nikko Chemicals Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 163. Nikko Chemicals Liposomes for Drug Delivery Product
Table 164. Nikko Chemicals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Liposomes for Drug Delivery Distributors List
Table 168. Liposomes for Drug Delivery Customers List
Table 169. Liposomes for Drug Delivery Market Trends
Table 170. Liposomes for Drug Delivery Market Drivers
Table 171. Liposomes for Drug Delivery Market Challenges
Table 172. Liposomes for Drug Delivery Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Liposomes for Drug Delivery
Figure 2. Global Liposomes for Drug Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomes for Drug Delivery Market Share by Type: 2024 & 2031
Figure 4. Liposome Vitamin Product Picture
Figure 5. Liposome Ceramide Product Picture
Figure 6. Liposome CoQ10 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Liposomes for Drug Delivery Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Liposomes for Drug Delivery Market Share by Application: 2024 & 2031
Figure 10. Hydrophilic Drugs
Figure 11. Hydrophobic Drugs
Figure 12. Global Liposomes for Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Liposomes for Drug Delivery Market Size (2020-2031) & (US$ Million)
Figure 14. Global Liposomes for Drug Delivery Sales (2020-2031) & (Tons)
Figure 15. Global Liposomes for Drug Delivery Average Price (US$/Kg) & (2020-2031)
Figure 16. Liposomes for Drug Delivery Report Years Considered
Figure 17. Liposomes for Drug Delivery Sales Share by Manufacturers in 2024
Figure 18. Global Liposomes for Drug Delivery Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Liposomes for Drug Delivery Players: Market Share by Revenue in Liposomes for Drug Delivery in 2024
Figure 20. Liposomes for Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Liposomes for Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 23. North America Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 24. United States Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 27. Europe Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 28. Germany Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Liposomes for Drug Delivery Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Liposomes for Drug Delivery Revenue Market Share by Region (2020-2031)
Figure 35. China Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 45. Latin America Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Liposomes for Drug Delivery by Type (2020-2031)
Figure 55. Global Revenue Market Share of Liposomes for Drug Delivery by Type (2020-2031)
Figure 56. Global Liposomes for Drug Delivery Price (US$/Kg) by Type (2020-2031)
Figure 57. Global Sales Market Share of Liposomes for Drug Delivery by Application (2020-2031)
Figure 58. Global Revenue Market Share of Liposomes for Drug Delivery by Application (2020-2031)
Figure 59. Global Liposomes for Drug Delivery Price (US$/Kg) by Application (2020-2031)
Figure 60. Liposomes for Drug Delivery Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Liposomes for Drug Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Liposomes for Drug Delivery Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Liposomes for Drug Delivery Market Competitive Situation by Manufacturers in 2024
Table 4. Global Liposomes for Drug Delivery Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Liposomes for Drug Delivery Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Liposomes for Drug Delivery Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Liposomes for Drug Delivery Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Liposomes for Drug Delivery Average Price (US$/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Liposomes for Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Liposomes for Drug Delivery, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liposomes for Drug Delivery, Product Type & Application
Table 12. Global Key Manufacturers of Liposomes for Drug Delivery, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomes for Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes for Drug Delivery as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liposomes for Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Liposomes for Drug Delivery Sales by Region (2020-2025) & (Tons)
Table 18. Global Liposomes for Drug Delivery Sales Market Share by Region (2020-2025)
Table 19. Global Liposomes for Drug Delivery Sales by Region (2026-2031) & (Tons)
Table 20. Global Liposomes for Drug Delivery Sales Market Share by Region (2026-2031)
Table 21. Global Liposomes for Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Liposomes for Drug Delivery Revenue Market Share by Region (2020-2025)
Table 23. Global Liposomes for Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Liposomes for Drug Delivery Revenue Market Share by Region (2026-2031)
Table 25. North America Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 27. North America Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 28. North America Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 32. Europe Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 33. Europe Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Liposomes for Drug Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Liposomes for Drug Delivery Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Liposomes for Drug Delivery Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Liposomes for Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Liposomes for Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Liposomes for Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Liposomes for Drug Delivery Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Liposomes for Drug Delivery Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Liposomes for Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Liposomes for Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Liposomes for Drug Delivery Sales (Tons) by Type (2020-2025)
Table 51. Global Liposomes for Drug Delivery Sales (Tons) by Type (2026-2031)
Table 52. Global Liposomes for Drug Delivery Sales Market Share by Type (2020-2025)
Table 53. Global Liposomes for Drug Delivery Sales Market Share by Type (2026-2031)
Table 54. Global Liposomes for Drug Delivery Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Liposomes for Drug Delivery Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Liposomes for Drug Delivery Revenue Market Share by Type (2020-2025)
Table 57. Global Liposomes for Drug Delivery Revenue Market Share by Type (2026-2031)
Table 58. Global Liposomes for Drug Delivery Price (US$/Kg) by Type (2020-2025)
Table 59. Global Liposomes for Drug Delivery Price (US$/Kg) by Type (2026-2031)
Table 60. Global Liposomes for Drug Delivery Sales (Tons) by Application (2020-2025)
Table 61. Global Liposomes for Drug Delivery Sales (Tons) by Application (2026-2031)
Table 62. Global Liposomes for Drug Delivery Sales Market Share by Application (2020-2025)
Table 63. Global Liposomes for Drug Delivery Sales Market Share by Application (2026-2031)
Table 64. Global Liposomes for Drug Delivery Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Liposomes for Drug Delivery Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Liposomes for Drug Delivery Revenue Market Share by Application (2020-2025)
Table 67. Global Liposomes for Drug Delivery Revenue Market Share by Application (2026-2031)
Table 68. Global Liposomes for Drug Delivery Price (US$/Kg) by Application (2020-2025)
Table 69. Global Liposomes for Drug Delivery Price (US$/Kg) by Application (2026-2031)
Table 70. Lipoid Kosmetik Company Information
Table 71. Lipoid Kosmetik Description and Business Overview
Table 72. Lipoid Kosmetik Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 73. Lipoid Kosmetik Liposomes for Drug Delivery Product
Table 74. Lipoid Kosmetik Recent Developments/Updates
Table 75. Lucas Meyer Cosmetics Company Information
Table 76. Lucas Meyer Cosmetics Description and Business Overview
Table 77. Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. Lucas Meyer Cosmetics Liposomes for Drug Delivery Product
Table 79. Lucas Meyer Cosmetics Recent Developments/Updates
Table 80. Nippon Fine Chemical Company Information
Table 81. Nippon Fine Chemical Description and Business Overview
Table 82. Nippon Fine Chemical Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. Nippon Fine Chemical Liposomes for Drug Delivery Product
Table 84. Nippon Fine Chemical Recent Developments/Updates
Table 85. Enoc Solutions Company Information
Table 86. Enoc Solutions Description and Business Overview
Table 87. Enoc Solutions Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. Enoc Solutions Liposomes for Drug Delivery Product
Table 89. Enoc Solutions Recent Developments/Updates
Table 90. Nanovec Company Information
Table 91. Nanovec Description and Business Overview
Table 92. Nanovec Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Nanovec Liposomes for Drug Delivery Product
Table 94. Nanovec Recent Developments/Updates
Table 95. Lipotec Company Information
Table 96. Lipotec Description and Business Overview
Table 97. Lipotec Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. Lipotec Liposomes for Drug Delivery Product
Table 99. Lipotec Recent Developments/Updates
Table 100. Croda Company Information
Table 101. Croda Description and Business Overview
Table 102. Croda Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. Croda Liposomes for Drug Delivery Product
Table 104. Croda Recent Developments/Updates
Table 105. H&A Pharmachem Company Information
Table 106. H&A Pharmachem Description and Business Overview
Table 107. H&A Pharmachem Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 108. H&A Pharmachem Liposomes for Drug Delivery Product
Table 109. H&A Pharmachem Recent Developments/Updates
Table 110. Lipomize Company Information
Table 111. Lipomize Description and Business Overview
Table 112. Lipomize Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 113. Lipomize Liposomes for Drug Delivery Product
Table 114. Lipomize Recent Developments/Updates
Table 115. ID bio Company Information
Table 116. ID bio Description and Business Overview
Table 117. ID bio Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 118. ID bio Liposomes for Drug Delivery Product
Table 119. ID bio Recent Developments/Updates
Table 120. BioSpectrum Company Information
Table 121. BioSpectrum Description and Business Overview
Table 122. BioSpectrum Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 123. BioSpectrum Liposomes for Drug Delivery Product
Table 124. BioSpectrum Recent Developments/Updates
Table 125. Derma Clinical Company Information
Table 126. Derma Clinical Description and Business Overview
Table 127. Derma Clinical Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 128. Derma Clinical Liposomes for Drug Delivery Product
Table 129. Derma Clinical Recent Developments/Updates
Table 130. Kewpie Corporation Company Information
Table 131. Kewpie Corporation Description and Business Overview
Table 132. Kewpie Corporation Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 133. Kewpie Corporation Liposomes for Drug Delivery Product
Table 134. Kewpie Corporation Recent Developments/Updates
Table 135. Nanohealth Biotech Company Information
Table 136. Nanohealth Biotech Description and Business Overview
Table 137. Nanohealth Biotech Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 138. Nanohealth Biotech Liposomes for Drug Delivery Product
Table 139. Nanohealth Biotech Recent Developments/Updates
Table 140. Creative Biostructure Company Information
Table 141. Creative Biostructure Description and Business Overview
Table 142. Creative Biostructure Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 143. Creative Biostructure Liposomes for Drug Delivery Product
Table 144. Creative Biostructure Recent Developments/Updates
Table 145. Phenbiox Company Information
Table 146. Phenbiox Description and Business Overview
Table 147. Phenbiox Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 148. Phenbiox Liposomes for Drug Delivery Product
Table 149. Phenbiox Recent Developments/Updates
Table 150. NOF CORPORATION Company Information
Table 151. NOF CORPORATION Description and Business Overview
Table 152. NOF CORPORATION Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 153. NOF CORPORATION Liposomes for Drug Delivery Product
Table 154. NOF CORPORATION Recent Developments/Updates
Table 155. KYOWA PHARMA CHEMICAL Company Information
Table 156. KYOWA PHARMA CHEMICAL Description and Business Overview
Table 157. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 158. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product
Table 159. KYOWA PHARMA CHEMICAL Recent Developments/Updates
Table 160. Nikko Chemicals Company Information
Table 161. Nikko Chemicals Description and Business Overview
Table 162. Nikko Chemicals Liposomes for Drug Delivery Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 163. Nikko Chemicals Liposomes for Drug Delivery Product
Table 164. Nikko Chemicals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Liposomes for Drug Delivery Distributors List
Table 168. Liposomes for Drug Delivery Customers List
Table 169. Liposomes for Drug Delivery Market Trends
Table 170. Liposomes for Drug Delivery Market Drivers
Table 171. Liposomes for Drug Delivery Market Challenges
Table 172. Liposomes for Drug Delivery Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Liposomes for Drug Delivery
Figure 2. Global Liposomes for Drug Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomes for Drug Delivery Market Share by Type: 2024 & 2031
Figure 4. Liposome Vitamin Product Picture
Figure 5. Liposome Ceramide Product Picture
Figure 6. Liposome CoQ10 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Liposomes for Drug Delivery Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Liposomes for Drug Delivery Market Share by Application: 2024 & 2031
Figure 10. Hydrophilic Drugs
Figure 11. Hydrophobic Drugs
Figure 12. Global Liposomes for Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Liposomes for Drug Delivery Market Size (2020-2031) & (US$ Million)
Figure 14. Global Liposomes for Drug Delivery Sales (2020-2031) & (Tons)
Figure 15. Global Liposomes for Drug Delivery Average Price (US$/Kg) & (2020-2031)
Figure 16. Liposomes for Drug Delivery Report Years Considered
Figure 17. Liposomes for Drug Delivery Sales Share by Manufacturers in 2024
Figure 18. Global Liposomes for Drug Delivery Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Liposomes for Drug Delivery Players: Market Share by Revenue in Liposomes for Drug Delivery in 2024
Figure 20. Liposomes for Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Liposomes for Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 23. North America Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 24. United States Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 27. Europe Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 28. Germany Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Liposomes for Drug Delivery Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Liposomes for Drug Delivery Revenue Market Share by Region (2020-2031)
Figure 35. China Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 45. Latin America Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Liposomes for Drug Delivery Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Liposomes for Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Liposomes for Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Liposomes for Drug Delivery by Type (2020-2031)
Figure 55. Global Revenue Market Share of Liposomes for Drug Delivery by Type (2020-2031)
Figure 56. Global Liposomes for Drug Delivery Price (US$/Kg) by Type (2020-2031)
Figure 57. Global Sales Market Share of Liposomes for Drug Delivery by Application (2020-2031)
Figure 58. Global Revenue Market Share of Liposomes for Drug Delivery by Application (2020-2031)
Figure 59. Global Liposomes for Drug Delivery Price (US$/Kg) by Application (2020-2031)
Figure 60. Liposomes for Drug Delivery Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232